JUN 19, 2019 11:00 AM PDT

Selecting the right tools to build your pluripotent stem cell based disease models

Speaker

Abstract
DATE:   June 19, 2019
TIME:    11:00am PDT, 2:00pm EDT
 
 
Human induced pluripotent stem cells (hiPSCs) have been globally recognized as a multipurpose research tool for modeling human disease and biology, screening and developing potential therapeutic drugs, and implementing cell and gene therapies. The ability to differentiate human iPSCs into any cell type supports the study of biology and disease in these specified cells in vitro. The emergence of genome editing tools, inlcuding the CRISPR/Cas9 system or TALENs, enable genetic modification of these cells; such as introduction of single base changes or inserting reporters or bio-sensors, which can be used to study the effects of genetic differences or biological functions in the desired cell type. Given the challenges with genome editing efficiency, cell survival and clonal isolation, we have developed a number of reagents and processes to dramatically improve the success rate and timelines for a genome editing experiment in hiPSCs. Key areas of the genome editing workflow that have been addressed include the genome editing tools themselves, the delivery methods and the maintenance of healthy hiPSC cultures during these stressful manipulations. Using the generation of disease models relevant to cardiac and neuronal disease to explore and identify the best workflow for the genome editing process in hiPSC, we built a reliable approach that reproducibly supports the generation of hiPSC lines carrying small mutations such as SNPs or small deletions. Subsequent studies of the disease relevant cell types then identified cellular phenotypes that corroborated with those previously identified in patient-derived hiPSC-based models. In summary, we detail advances with tools, reagents and protocols that facilitate the genome editing workflow in hiPSC and demonstrate that the use of such tools can be readily implemented to generate hiPSC-derived disease models and reporter lines.
 
 
Learning Objectives:
  • Selecting the right tools are key for successful genome editing in PSC
  • Successful clonal isolation of PSC heavily depends on medium choice.
 
 
Webinars will be available for unlimited on-demand viewing after live event.
 
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

Show Resources
You May Also Like
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
JUN 28, 2022 7:00 AM PDT
JUN 28, 2022 7:00 AM PDT
Date: June 28, 2022 Time: 3:00pm (BST), 4:00pm (CET), 9:00am (CST), 7am (PST) Light-sheet microscopy is an extremely versatile imaging technique with a vast range of implementations that are...
AUG 24, 2022 7:00 AM PDT
AUG 24, 2022 7:00 AM PDT
Date: August 24, 2022 Time: 7:00am (PDT), 10:00pm (EDT), 4:00pm (CEST) Light field microscopy was first introduced in 2006, and allows users to capture the 4D light field within the microsco...
SEP 22, 2022 9:00 AM PDT
SEP 22, 2022 9:00 AM PDT
Date: September 22, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) Optimizing platforms for surgical specimen collection and deep human phenotyping was used to enhance protein biomarke...
JUN 21, 2022 6:00 AM PDT
JUN 21, 2022 6:00 AM PDT
Date: June 21, 2022 Time: 6:00am (PDT), 9:00am (EDT), 3:00pm (CEST) The global understanding and practice of medicine is currently undergoing a revolutionary change. This shift to precision...
APR 26, 2022 7:00 AM PDT
C.E. CREDITS
APR 26, 2022 7:00 AM PDT
Date: April 19, 2022 Time: 7:00am (PDT), 10:00am (EDT), 4:00pm (CEST) High-content (HC) phenotypic profiling approaches are a powerful tool to study the effect of biological, genetic, and ch...
JUN 19, 2019 11:00 AM PDT

Selecting the right tools to build your pluripotent stem cell based disease models



Show Resources
Loading Comments...
Show Resources